Welcome to AusBio

Aus Bio Ltd. is a public but unlisted, Melbourne based biotechnology research and development company (R&D). Principal objectives are:

1. Development of an innovative research program to create new therapeutic products for specific disease states eg influenza.
2. Create significant scientific and commercial alliances.
3. Increase shareholder value.

Influenza

Aus Bio’s MD2009 project has resulted in the pre-clinical development of a number of antiviral drug candidates which have a different mode of action to the currently used neuraminidase inhibitors.

Respiratory

Aus Bio’s Respiratory Project – MD990 – has resulted from the identification of several specific carbohydrates, which have been shown to influence and enhance recovery of injured human respiratory cells.

Diabetes

Aus Bio has worked with an internationally recognised Melbourne-based cardiovascular and diabetes institute to add value to the diabetes program.